Literature DB >> 19468250

Poly(ADP-ribose) polymerase inhibition down-regulates expression of metastasis-related genes in CT26 colon carcinoma cells.

Ming Li1, Michael D Threadgill, Yalan Wang, Li Cai, Xiao Lin.   

Abstract

OBJECTIVES: The current study was designed to test the hypothesis that inhibition of poly(ADP-ribose) polymerase in colorectal cancer mediates down-regulation of metastasis-related gene expression through the regulation of nuclear factor-kappaB (NF-kappaB) activity.
METHODS: Mouse colon carcinoma cells (CT26) were treated with and without the PARP inhibitor 5-aminoisoquinolin-1(2H)-one hydrochloride (5-AIQ). We investigated adhesion, migration and invasion of differently treated CT26 cells. In addition, the expression levels of PARP, NF-kappaB, integrin beta(1), MMP-9 and MMP-2 as well as the activities of NF-kappaB, MMP-9 and MMP-2 were determined by Western blot, electrophoretic mobility gel shift assay and zymography, respectively.
RESULTS: Inhibition ofPARP attenuated the adhesion of CT26 cells to the extracellular matrix and their migration and invasion through Matrigel. In addition, the results of Western blot showed that the expression levels of PARP, NF-kappaB, integrin beta(1), MMP-9 and MMP-2 were reduced in 5-AIQ-treated CT26 cells; the activities of NF-kappaB, MMP-9 and MMP-2 were also suppressed.
CONCLUSIONS: Inhibition of PARP down-regulates the expression of metastasis-related genes in mouse colon carcinoma cells. This could be, at least in part, through the regulation of NF-kappaB activity, but the precise mechanisms of action remain to be elucidated. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19468250     DOI: 10.1159/000209388

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  7 in total

1.  Mechanistic insight into the ability of American ginseng to suppress colon cancer associated with colitis.

Authors:  Xiangli Cui; Yu Jin; Deepak Poudyal; Alexander A Chumanevich; Tia Davis; Anthony Windust; Anne Hofseth; Wensong Wu; Joshua Habiger; Edsel Pena; Patricia Wood; Mitzi Nagarkatti; Prakash S Nagarkatti; Lorne Hofseth
Journal:  Carcinogenesis       Date:  2010-08-20       Impact factor: 4.944

Review 2.  PARP and PARG inhibitors--new therapeutic targets in cancer treatment.

Authors:  Nilufer Jasmine Selimah Fauzee; Juan Pan; Ya-lan Wang
Journal:  Pathol Oncol Res       Date:  2010-04-12       Impact factor: 3.201

3.  Silencing Poly (ADP-Ribose) glycohydrolase (PARG) expression inhibits growth of human colon cancer cells in vitro via PI3K/Akt/NFκ-B pathway.

Authors:  Nilufer Jasmine Selimah Fauzee; Qiaozhuan Li; Ya-Lan Wang; Juan Pan
Journal:  Pathol Oncol Res       Date:  2011-06-30       Impact factor: 3.201

4.  Transgelin interacts with PARP1 in human colon cancer cells.

Authors:  Zhen-Xian Lew; Hui-Min Zhou; Yuan-Yuan Fang; Zhen Ye; Wa Zhong; Xin-Yi Yang; Zhong Yu; Dan-Yu Chen; Si-Min Luo; Li-Fei Chen; Ying Lin
Journal:  Cancer Cell Int       Date:  2020-08-03       Impact factor: 5.722

5.  High PARP-1 expression is associated with tumor invasion and poor prognosis in gastric cancer.

Authors:  Ying Liu; Yu Zhang; Ying Zhao; Dongna Gao; Jing Xing; Hui Liu
Journal:  Oncol Lett       Date:  2016-09-22       Impact factor: 2.967

6.  PARP-1 depletion in combination with carbon ion exposure significantly reduces MMPs activity and overall increases TIMPs expression in cultured HeLa cells.

Authors:  Atanu Ghorai; Asitikantha Sarma; Priyanka Chowdhury; Utpal Ghosh
Journal:  Radiat Oncol       Date:  2016-09-22       Impact factor: 3.481

7.  Rosmarinic Acid Activates AMPK to Inhibit Metastasis of Colorectal Cancer.

Authors:  Yo-Han Han; Ji-Ye Kee; Seung-Heon Hong
Journal:  Front Pharmacol       Date:  2018-02-05       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.